Aurora Cannabis (ACB.US) stock plunged more than 6.0% after the company reported lower than expected Q3 figures. Cannabis producers lost 85 Canadian cents per share, while analysts expected a much smaller loss of 21 Canadian cents per share. Revenue of 55.161 million Canadian dollars also came in below estimates for 66.92 million Canadian dollars. Medical cannabis net sales rose 17% however adult-use cannabis sales dropped 53%. Aurora attributed the drop in recreational weed sales partially due to pandemic-related restrictions in Canada. Separately, Aurora announced a move in its U.S. stock listing to Nasdaq from the New York Stock Exchange, citing lower costs.
Aurora Cannabis (ACB.US) stock launched today's session with a bearish price gap and is approaching the lower limit of the descending channel which coincides with local support at $6.55. Should break lower occur, then downward move may be extended to the next support at $3.80. On the other hand, if buyers will manage to halt decline here, then upward impulse towards resistance at $9.25 could be launched. Source: xStation5
The content of this report has been created by X-Trade Brokers Dom Maklerski S.A., with its registered office in Warsaw, at Ogrodowa 58, 00-876 Warsaw, Poland, (KRS number 0000217580) and supervised by Polish Supervision Authority ( No. DDM-M-4021-57-1/2005). This material is a marketing communication within the meaning of Art. 24 (3) of Directive 2014/65/EU of the European Parliament and of the Council of 15 May 2014 on markets in financial instruments and amending Directive 2002/92/EC and Directive 2011/61/EU (MiFID II). Marketing communication is not an investment recommendation or information recommending or suggesting an investment strategy within the meaning of Regulation (EU) No 596/2014 of the European Parliament and of the Council of 16 April 2014 on market abuse (market abuse regulation) and repealing Directive 2003/6/EC of the European Parliament and of the Council and Commission Directives 2003/124/EC, 2003/125/EC and 2004/72/EC and Commission Delegated Regulation (EU) 2016/958 of 9 March 2016 supplementing Regulation (EU) No 596/2014 of the European Parliament and of the Council with regard to regulatory technical standards for the technical arrangements for objective presentation of investment recommendations or other information recommending or suggesting an investment strategy and for disclosure of particular interests or indications of conflicts of interest or any other advice, including in the area of investment advisory, within the meaning of the Trading in Financial Instruments Act of 29 July 2005 (i.e. Journal of Laws 2019, item 875, as amended). The marketing communication is prepared with the highest diligence, objectivity, presents the facts known to the author on the date of preparation and is devoid of any evaluation elements. The marketing communication is prepared without considering the client’s needs, his individual financial situation and does not present any investment strategy in any way. The marketing communication does not constitute an offer of sale, offering, subscription, invitation to purchase, advertisement or promotion of any financial instruments. X-Trade Brokers Dom Maklerski S.A. is not liable for any client’s actions or omissions, in particular for the acquisition or disposal of financial instruments, undertaken on the basis of the information contained in this marketing communication. In the event that the marketing communication contains any information about any results regarding the financial instruments indicated therein, these do not constitute any guarantee or forecast regarding the future results.